Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol Medical Dialogues Bureau10 April 2020 4:30 AM GMTMumbai: Cipla Limited has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalatio...
Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus Medical Dialogues Bureau5 April 2020 9:11 AM GMTMumbai: Cipla Limited has announced the successful completion of the Phase-3 clinical end-point study for fluticasone propionate and salmeterol inhalat...
NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir Medical Dialogues Bureau29 March 2020 7:49 AM GMTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
Cipla gets USFDA final nod for Esomeprazole ANDA for Oral Suspension Medical Dialogues Bureau27 March 2020 7:21 AM GMTCipla's Esomeprazole for Oral Suspension 10mg, 20mg and 40mg is an AB-rated generic therapeutic equivalent version of AstraZeneca Pharmaceutical's ...
Cipla joins hands with CSIR-IICT to develop coronavirus drug Medical Dialogues Bureau19 March 2020 6:40 AM GMTHyderabad: Hyderabad-based CSIR-Indian Institute of Chemical Technology (IICT) has tied up with pharmaceutical giant Cipla to work on the develop...
Dr VG Somani DCGI releases IPA guidelines on Market Complaints. Medical Dialogues Bureau2 March 2020 5:00 AM GMTThe guidelines were released at the recently concluded India Pharmaceutical Forum
